MIRA

MIRA Pharmaceuticals, Inc. Common Stock

1.01

USD

MIRA Earnings Reports

Positive Surprise Ratio

MIRA beat 5 of 8 last estimates.

63%

Next Report

Date of Next Report

Apr 15, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.04

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-73.33%

MIRA Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On --, MIRA reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.04 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Kyntra Bio, Inc. Common Stock

Report Date

Mar 16, 2026 For Q4 25

Estimate

-$3.96

Actual

-$3.61

Surprise

+8.90%

Longeveron Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.42

Actual

-$0.22

Surprise

+48.03%

Trevi Therapeutics, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.06

Surprise

+40.06%

Olema Pharmaceuticals, Inc. Common Stock

Report Date

Mar 16, 2026 For Q4 25

Estimate

-$0.53

Actual

-$0.50

Surprise

+7.29%

Alvotech Ordinary Shares

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.37

Surprise

-706.10%

XOMA Royalty Corporation Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.15

Actual

$0.12

Surprise

+175.90%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

Abeona Therapeutics Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.36

Actual

-$0.34

Surprise

+6.28%

Protalix BioTherapeutics, Inc. Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

$0.00

Actual

-$0.07

Surprise

-1472.55%

Artiva Biotherapeutics, Inc. Common Stock

Report Date

Mar 30, 2026 For Q4 25

Estimate

-$0.84

Actual

Surprise

FAQ

What were MIRA Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?

For Q-- --, MIRA Pharmaceuticals, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to MIRA Pharmaceuticals, Inc. Common Stock's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is MIRA Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Apr 15, 2026.

What are the forecasts for MIRA Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 3 analysts, MIRA Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.04 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.